tiprankstipranks
Trending News
More News >
Citius Pharma (CTXR)
NASDAQ:CTXR
US Market

Citius Pharmaceuticals (CTXR) Income Statement

Compare
1,772 Followers

Citius Pharmaceuticals Income Statement

Last quarter (Q3 2025), Citius Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Citius Pharmaceuticals's net income was $-8.79M. See Citius Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -214.25K$ -209.61K$ -194.32K$ -179.68K$ -164.87K
Operating Expenses
$ 38.31M$ 42.00M$ 36.73M$ 33.32M$ 23.53M
Depreciation and Amortization
$ 214.25K$ 209.61K$ 194.32K$ 179.68K$ 164.87K
EBITDA
$ -38.20M$ -38.64M$ -31.77M$ -32.88M$ -22.88M
Operating Income
$ -38.53M$ -42.00M$ -36.73M$ -33.32M$ -23.53M
Other Income/Expenses
$ -157.70K$ 3.15M$ 4.77M$ 251.40K$ 477.46K
Pretax Income
$ -38.68M$ -38.85M$ -31.97M$ -33.06M$ -23.05M
Net Income
$ -37.43M$ -39.14M$ -32.54M$ -33.64M$ -23.13M
Per Share Metrics
Basic EPS
$ -3.38$ -5.97$ -5.57$ -5.76$ -5.64
Diluted EPS
$ -3.38$ -5.97$ -5.57$ -5.76$ -5.64
Weighted Average Shares Outstanding
11.07M 11.59M 9.74M 9.74M 7.24M
Weighted Average Shares Outstanding (Diluted)
11.07M 11.59M 10.09M 9.74M 7.24M
Currency in USD

Citius Pharmaceuticals Earnings and Revenue History